P. Hodgkins

1.0k total citations
37 papers, 694 citations indexed

About

P. Hodgkins is a scholar working on Psychiatry and Mental health, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, P. Hodgkins has authored 37 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Psychiatry and Mental health, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in P. Hodgkins's work include Attention Deficit Hyperactivity Disorder (16 papers), Cystic Fibrosis Research Advances (6 papers) and Inflammatory Bowel Disease (5 papers). P. Hodgkins is often cited by papers focused on Attention Deficit Hyperactivity Disorder (16 papers), Cystic Fibrosis Research Advances (6 papers) and Inflammatory Bowel Disease (5 papers). P. Hodgkins collaborates with scholars based in United States, United Kingdom and France. P. Hodgkins's co-authors include Moshe Fridman, Jennifer Kahle, Ottilie Sedgwick, Susan Young, Luigi Mazzone, Jean‐Philippe Raynaud, Valerie Harpin, Donald Moss, Rafael A. González and Evelina A. Zimovetz and has published in prestigious journals such as American Journal of Epidemiology, Annals of Oncology and Psychological Medicine.

In The Last Decade

P. Hodgkins

36 papers receiving 673 citations

Peers

P. Hodgkins

PMH

SURGE

DEP

Andrea E. Spencer United States

Marc Ferrer Spain

Cem Gökçen Türkiye

Elisabeth Northam Australia

Kenneth Park United States

Mary K. Morris United States

Alison E. Pritchard United States

Sarah Williamson United States

Bahar Gökler Türkiye

Yafit Gilboa Israel

Andrea E. Spencer United States

P. Hodgkins

283 ×0.6

PMH

197 ×0.8

155 ×0.8

17 ×0.2

SURGE

24 ×0.3

DEP

Citations per year, relative to P. Hodgkins P. Hodgkins (= 1×) peers Andrea E. Spencer

Countries citing papers authored by P. Hodgkins

Since Specialization

Citations

This map shows the geographic impact of P. Hodgkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Hodgkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Hodgkins more than expected).

Fields of papers citing papers by P. Hodgkins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Hodgkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Hodgkins. The network helps show where P. Hodgkins may publish in the future.

Co-authorship network of co-authors of P. Hodgkins

This figure shows the co-authorship network connecting the top 25 collaborators of P. Hodgkins. A scholar is included among the top collaborators of P. Hodgkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Hodgkins. P. Hodgkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rider, Jennifer R., Asher Wasserman, Gillis Carrigan, et al.. (2024). Emulations of oncology trials using real-world data: a systematic literature review. American Journal of Epidemiology. 194(6). 1783–1793. 1 indexed citations

Mozaffari, Essy, et al.. (2021). PIN82 Real-World Utilization of Remdesivir in 2020: A Retrospective Cohort Study. Value in Health. 24. S121–S121. 1 indexed citations

Bonthapally, Vijayveer, Ellison Suthoff, P. Hodgkins, et al.. (2018). PMH76 - PATIENT REPORTED MEASURES OF DEPRESSIVE SYMPTOMS AND FATIGUE IN A PHASE 2, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF THE GABAA RECEPTOR POSITIVE ALLOSTERIC MODULATOR SAGE-217 IN MAJOR DEPRESSIVE DISORDER. Value in Health. 21. S287–S287. 1 indexed citations

Limone, Brendan, et al.. (2016). The Burden Of Cystic Fibrosis: Pulmonary Exacerbations And Health Care Resource Utilization In A Commercially Insured Population In The United States. Value in Health. 19(3). A115–A115. 3 indexed citations

Fridman, Moshe, P. Hodgkins, Jennifer Kahle, & M. Haim Erder. (2015). Predicted effect size of lisdexamfetamine treatment of attention deficit/hyperactivity disorder (ADHD) in European adults: Estimates based on indirect analysis using a systematic review and meta-regression analysis. European Psychiatry. 30(4). 521–527. 13 indexed citations

Wagener, Jeffrey S., et al.. (2015). Clinical and Economic Burden of Pulmonary Excerbations In Patients With Cystic Fibrosis Who are Homozygous For The F508del Mutation. Value in Health. 18(7). A658–A659. 2 indexed citations

Young, Susan, Donald Moss, Ottilie Sedgwick, Moshe Fridman, & P. Hodgkins. (2014). A meta-analysis of the prevalence of attention deficit hyperactivity disorder in incarcerated populations. Psychological Medicine. 45(2). 247–258. 179 indexed citations

Roskell, Neil, Juliana Setyawan, Evelina A. Zimovetz, & P. Hodgkins. (2014). Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine. Current Medical Research and Opinion. 30(8). 1673–1685. 34 indexed citations

Pokrzywinski, Robin, et al.. (2013). Development of a conceptual disease model to inform strategy to evaluate treatment impact in adolescents with attention deficit hyperactivity disorder (ADHD). Value in Health. 16(3). A64–A65. 2 indexed citations

10.

Zimovetz, Evelina A., Juliana Setyawan, S Beard, & P. Hodgkins. (2012). PMH37 Systematic Review of Health State Utilities in Attention Deficit Hyperactivity Disorder (ADHD). Value in Health. 15(7). A340–A340. 2 indexed citations

11.

Wu, Jun, et al.. (2012). PGI29 Predictors of Nonpersistence and Nonadherence with Oral 5-Aminosalicylic Acid Therapy in Patients with Ulcerative Colitis. Value in Health. 15(4). A140–A140. 1 indexed citations

12.

Roskell, Neil, Juliana Setyawan, Evelina A. Zimovetz, & P. Hodgkins. (2012). PMH5 Systematic Review and Network Meta-Analysis of Treatments Used for Attention Deficit Hyperactivity Disorder (ADHD). Value in Health. 15(7). A334–A334. 2 indexed citations

13.

Setyawan, Juliana, P. Hodgkins, A. Guérin, et al.. (2012). Comparison of discontinuation risk in patients initiated on lisdexamfetamine dimesylate (LDX) vs. other medications for the treatment of attention deficit/hyperactivity disorder (ADHD): A retrospective claims analysis. Neuropsychiatrie de l Enfance et de l Adolescence. 60(5). S261–S261. 1 indexed citations

14.

Yarlas, Aaron, et al.. (2011). PGI28 Disease-Specific Health-related Quality of Life in Patients with Quiescent Ulcerative Colitis: Effects of one Year Maintenance Treatment with MMX Mesalamine. Value in Health. 14(7). A396–A397. 2 indexed citations

15.

Erder, M. Haim, et al.. (2011). PMH37 THE COST-EFFECTIVENESS OF GUANFACINE EXTENDED RELEASE (GXR) VERSUS ATOMOXETINE (ATX) FOR THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN CHILDREN AND ADOLESCENTS. Value in Health. 14(3). A192–A192. 1 indexed citations

16.

Lachaîne, Jean, et al.. (2011). PGI23 Economic Impact of Medication Adherence and Persistence in the Treatment of Ulcerative Colitis in Canada: Analyses with the Ramq Database. Value in Health. 14(7). A395–A396. 2 indexed citations

17.

Sikirica, Vanja, M. Haim Erder, Jipan Xie, et al.. (2011). PIH23 Cost-Effectiveness of Guanfacine Extended Release as an Adjunctive Therapy to a Psychostimulant Compared to Psychostimulant Monotherapy for the Treatment of Attention Deficit/Hyperactivity Disorder in Children and Adolescents. Value in Health. 14(7). A401–A402. 1 indexed citations

18.

Nicholls, R J, David Clark, Alison M. Crowe, et al.. (2010). Nationwide linkage analysis in Scotland implicates age as the critical overall determinant of mortality in ulcerative colitis. Alimentary Pharmacology & Therapeutics. 31(12). 1310–1321. 30 indexed citations

19.

Nicholls, R J, David Clark, Alison M. Crowe, et al.. (2010). PWE-029 Nationwide linkage analysis in Scotland implicates age as the critical overall determinant of mortality in ulcerative colitis. A96.1–A96. 3 indexed citations

20.

Schwarcz, Robert, Burkhard Pöeggeler, Arash Rassoulpour, Gianpiera Ceresoli‐Borroni, & P. Hodgkins. (1998). Regulation of kynurenic acid levels in the developing rat brain. Amino Acids. 14(1-3). 243–249. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact